IP Library › Granted Patent US 9,226,797
Granted Patent B2
US 9,226,797 · App. 14/255,952 · Granted Jan 5, 2016

Computer aided implantation of body implants

Inventors: Phi Nguyen (Houston, TX); Loc Phan (San Jose, CA); Bao Tran (Saratoga, CA); Thuan Nguyen (Houston, CA); Duy Bui (Ha Noi, VN)
Assignee: MIBA Medical Inc.
A61B19/50A61F2/02A61F2/12A61L27/3633A61M5/20A61B2019/504A61B2019/505A61F2250/0003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,226,797
App. No.
14/255,952
Granted
Jan 5, 2016
Kind
B2
Abstract

Systems and methods are disclosed for cosmetic injection. The apparatus includes a processor; a 3D imaging system coupled to the processor; and an injector controlled by the processor to inject filler into a patient.

Claims (28)

1. A method to perform cosmetic enhancements using a body sensor to provide body patient data to a processor and an injector controlled by the processor to inject filler into a patient, comprising

capturing a 3D model of a patient body portion using one or more cameras;

modeling shape and size change in the body portion due to an implant;

iteratively changing modeled body shapes or sizes until the patient is satisfied with a desired shape or size;

controlling the injector to deliver the implant in the patient; and

monitoring injection into patient and providing feedback if needed to achieve the desired shape and size.

2. The method of claim 1 , comprising morphing or project the shape/size of breast or butt increase onto the 3D model of patient.

3. The method of claim 1 , comprising allowing a user to select from a library of wardrobes to provide realistic post-implant simulation.

4. The method of claim 1 , comprising injecting a polymer into a shell of a soft tissue human implant prior to or during implantation of the shell with a lumen in a human body.

5. The method of claim 1 , comprising cross-linking the polymer, wherein a cross linking reaction occurs outside a shell or in-situ inside the shell.

6. The method of claim 1 , wherein the polymer comprises one of: collagens, hyaluronic acids, celluloses, proteins, saccharides.

7. The method of claim 1 , wherein the polymer comprises an extracellular matrix of a biological system.

8. The method of claim 1 , comprising using cross linkers and forming homo-polymers or to form copolymers by crosslinking with other polymer species.

9. The method of claim 1 , comprising controlling drug releases at predetermined timing in anticipation of an onset of a negative physiological event in response to invading foreign bodies.

10. The method of claim 1 , comprising injecting anesthetics, lidocaine or compound to reduce or eliminate acute inflammatory reactions to the pharmaceutical substance.

11. The method of claim 1 , comprising adding one or more compositions selected from the group consisting of steroids, corticosteroids, dexamethasone, triamcinolone.

12. An apparatus, comprising:

a processor;

a body sensor to provide body patient data to the processor; and

an injector controlled by the processor to inject filler into a patient.

13. The apparatus of claim 12 , wherein the injector includes a medicament container, a needle, an energy source, and a regulator.

14. The apparatus of claim 13 , wherein the injector medicament container has a piston movably disposed therein such that the medicament container is divided into a first portion and a second portion.

15. The apparatus of claim 14 , wherein the first portion of the medicament container is configured to contain a filler, wherein the needle is coupled to the medicament container such that the needle is in fluid communication with the first portion of the medicament container.

16. The apparatus of claim 1 , comprising a mechanical pump to inject the biocompatible cross-linked polymer under soft tissue in a minimally invasive manner.

17. The apparatus of claim 12 , wherein the processor optimizes degradation profile of the composition and minimizing migration of the composition.

18. The apparatus of claim 12 , wherein the filler has a predetermined number average molecular weight (Mn) and the polydispersity index, wherein the filler maintains a consistency of the composition in particle size and population densities, and wherein the filler comprises co-cross-linked glycosaminoglycan chemically with at least one other polymer including hyaluronan or hylan.

19. The apparatus of claim 12 , wherein the processor continuously updates the current shape of breast or butt from a 3D model of the patient to fit to a desired shape.

20. The apparatus of claim 12 , wherein the body sensor comprises a contact sensor or a contactless sensor.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2015
From: PHAN, LOC X; NGUYEN, PHI; TRAN, BAO
To: MIBA MEDICAL INC.
Reel/Frame 035826/0106 →
Continuity (2)
Provisional Application 61722221 · Nov 4, 2012
Related Publication 20150289945A1 · Oct 15, 2015